产品标题 产品货号 产品规格 厂家
Human ECSIT homolog (Drosophila) (ECSIT), transcript variant 3 from ORIGENE TECHNOLOGIESTP32759520 ugORIGENE TECHNOLOGIES
Human ectodermal-neural cortex (with BTB-like domain) (ENC1) from ORIGENE TECHNOLOGIESTP30184220 ugORIGENE TECHNOLOGIES
Human ectodysplasin A (EDA), transcript variant 3 from ORIGENE TECHNOLOGIESTP31562820 ugORIGENE TECHNOLOGIES
Human ectodysplasin A receptor (EDAR) from ORIGENE TECHNOLOGIESTP31086220 ugORIGENE TECHNOLOGIES
Human ecto-NOX disulfide-thiol exchanger 1 (ENOX1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30523220 ugORIGENE TECHNOLOGIES
Human ecto-NOX disulfide-thiol exchanger 1 (ENOX1), transcript variant 2 from ORIGENE TECHNOLOGIESTP32605520 ugORIGENE TECHNOLOGIES
Human ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3) from ORIGENE TECHNOLOGIESTP31291220 ugORIGENE TECHNOLOGIES
Human ecto-NOX disulfide-thiol exchanger 2 (ENOX2), transcript variant 1 from ORIGENE TECHNOLOGIESTP32420920 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor A (VEGFA), transcript variant 1 from ORIGENE TECHNOLOGIESTP780002200 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor A (VEGFA), transcript variant 2 from ORIGENE TECHNOLOGIESTP72380910 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor A (VEGFA), transcript variant 6 from ORIGENE TECHNOLOGIESTP72380410 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor A (VEGFA), transcript variant 7. from ORIGENE TECHNOLOGIESTP72347110 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor A (VEGFA), transcript variant 7. from ORIGENE TECHNOLOGIESTP72347210 ugORIGENE TECHNOLOGIES
Human Vascular endothelial growth factor A (VEGF) produced in Pichia Pastoris. from ORIGENE TECHNOLOGIESTP78000150 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor B (VEGFB) from ORIGENE TECHNOLOGIESTP30242620 ugORIGENE TECHNOLOGIES
Human vascular endothelial growth factor B (VEGFB). from ORIGENE TECHNOLOGIESTP72347320 ugORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium from ORIGENE TECHNOLOGIESCS6289035x5umORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS6002245x5umORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS7028995x5umORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIESCS5099845x5umORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIESCS8006535x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyoma of myometrium from ORIGENE TECHNOLOGIESCS8064015x5umORIGENE TECHNOLOGIES
Human Uterus; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS8000825x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyoma of myometrium from ORIGENE TECHNOLOGIESCS8064025x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7004425x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7067085x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7044085x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7088475x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8004035x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8043385x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8009925x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014185x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014195x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6010065x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5397415x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5014225x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6010075x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157115x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157915x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157925x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157125x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6166145x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6175975x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6196565x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6200875x5umORIGENE TECHNOLOGIES
Human Uterus; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6204425x5umORIGENE TECHNOLOGIES
Human Uterus and adnexa; Adenocarcinoma of endometrium or ovary, endometrioid from ORIGENE TECHNOLOGIESCS7038595x5umORIGENE TECHNOLOGIES
Human Uterus; Carcinosarcoma of endometrium from ORIGENE TECHNOLOGIESCS8049535x5umORIGENE TECHNOLOGIES
Human Uterus and adnexa; Adenocarcinoma of endometrium or ovary, endometrioid from ORIGENE TECHNOLOGIESCS7038585x5umORIGENE TECHNOLOGIES
Rat NGF/NGF beta ELISA Kit from ORIGENE TECHNOLOGIESEA1003298x12 divisible stripORIGENE TECHNOLOGIES
 |< < 5590 5591 5592 5593 5594 5595 5596 5597 5598 > >| 第 5592/6274 页